## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence presented in the supplied abstract
- **Shared manuscript claim summary** The abstract asserts that several computational approaches, including one-shot learning, structural modeling, molecular docking, scoring function space, molecular dynamics, and quantum mechanics, can mitigate low data availability in drug discovery, and that recent works demonstrate successful application of these techniques to challenging problems such as intrinsically disordered proteins and adverse effect evaluation.
- **Visible evidence base** Abstract text only; no figures, tables, methods, or reference list provided
- **Missing materials affecting confidence** Full manuscript text, methods descriptions, case study details, quantitative results, and reference list are absent, limiting verification of the claims

## Reviewer
- **Overall assessment** The abstract presents a plausible and timely overview of computational strategies for data-scarce drug discovery, but the evidence base is too limited to evaluate the strength of the claims. The narrative is coherent and the topic is relevant, yet the abstract lacks specific examples, quantitative outcomes, or comparative analyses that would substantiate the stated successes. The review nature of the work is clear, but the depth of critical assessment cannot be determined from the supplied material.
- **Who would be interested in the results, and why** Computational chemists, medicinal chemists, and drug discovery researchers facing data limitations would find this review useful. Those working on rare diseases, novel targets, or intrinsically disordered proteins may particularly benefit from the described approaches. The paper could also interest method developers seeking application areas for machine learning and simulation techniques.
- **Major strengths** The abstract addresses a genuine and growing concern in drug discovery, namely low data availability. It covers a broad range of computational methods, from machine learning to physics-based simulations, which provides a comprehensive perspective. The mention of specific challenging scenarios, such as intrinsically disordered proteins and adverse effect prediction, adds practical relevance.
- **Major Concerns** 
  - R1-M1
  - R1-M2
  - R1-M3
- **Minor Comments** 
  - R1-m1
  - R1-m2
  - R1-m3
- **Technical failings that need to be addressed before the case is established** The abstract does not provide any quantitative evidence, specific case outcomes, or methodological comparisons. Without these, the claim that these approaches "may be used to amplify the amount of available data" and that "recent works have successfully used these techniques" remains unverifiable. The review's critical evaluation of limitations and trade-offs among the methods is not evident from the abstract.
- **Assessment against Nature-style criteria** Originality: The topic is not novel in itself, as reviews on computational drug discovery are common, but the specific focus on low data availability and the combination of methods may offer a fresh angle. Scientific importance: The issue of data scarcity is significant, and a well-crafted review could be valuable, but the abstract does not demonstrate a unique contribution. Interdisciplinary readership: The content bridges machine learning, structural biology, and medicinal chemistry, which could attract a broad audience. Technical soundness: Cannot be assessed from the abstract alone; no methodological details or validation are provided. Readability for nonspecialists: The abstract is accessible, but the lack of concrete examples limits its explanatory power.
- **Recommendation posture** Currently not established from the provided evidence. The abstract suggests a potentially useful review, but the absence of substantive content prevents a supportive recommendation. A full manuscript with detailed case studies, critical comparisons, and explicit limitations would be required to assess the contribution.

### Major Concerns

- **Concern ID** R1-M1
- **Severity** Major
- **Blocking** Yes
- **Axis** Evidence sufficiency
- **Claim pointer** The abstract claims that "recent works have successfully used these techniques to solve a range of issues in the face of data scarcity."
- **Evidence pointer** Abstract text, location not provided
- **Concern** The abstract asserts successful applications but provides no specific examples, data, or citations to support this claim. The reader cannot verify which works are referenced, what problems were solved, or how success was measured.
- **Why it matters** A review's credibility depends on its ability to substantiate claims with concrete evidence. Without specific case studies or quantitative outcomes, the assertion of success is unsubstantiated and could mislead readers about the maturity of these methods.
- **Resolution test** The full manuscript should include detailed descriptions of at least two or three case studies, with clear problem statements, methods used, and quantitative results (for example, accuracy metrics, enrichment factors, or experimental validation). Each claim of success should be tied to a specific reference and outcome.

- **Concern ID** R1-M2
- **Severity** Major
- **Blocking** Yes
- **Axis** Scope and critical analysis
- **Claim pointer** The abstract states that "approaches that may help provide solutions to generate or obtain enough relevant data or improve/accelerate existing methods within the last five years were reviewed."
- **Evidence pointer** Abstract text, location not provided
- **Concern** The abstract does not indicate whether the review critically compares these methods, discusses their limitations, or provides guidance on method selection. A review that merely lists approaches without critical analysis has limited utility.
- **Why it matters** Readers need to understand the relative strengths and weaknesses of each approach to make informed decisions. Without critical comparison, the review risks being descriptive rather than instructive, which diminishes its value for practitioners.
- **Resolution test** The full manuscript should include a comparative discussion of the methods, addressing factors such as data requirements, computational cost, accuracy, and applicability domains. A summary table or decision framework would strengthen the contribution.

- **Concern ID** R1-M3
- **Severity** Major
- **Blocking** Yes
- **Axis** Reproducibility and transparency
- **Claim pointer** The abstract implies that the reviewed methods are ready for application, stating "it is possible to improve and kickstart research from scarce available data."
- **Evidence pointer** Abstract text, location not provided
- **Concern** The abstract does not mention any practical considerations for implementation, such as software availability, parameter settings, or validation protocols. This omission makes it difficult for readers to assess the feasibility of applying these methods in their own work.
- **Why it matters** For a review to be actionable, it must provide enough detail for readers to understand how to implement the methods. Lack of transparency about practical requirements undermines the stated potential of these approaches.
- **Resolution test** The full manuscript should include practical guidance, such as recommended software tools, typical workflows, and common pitfalls. Where possible, the authors should indicate whether code or tutorials are publicly available.

### Minor Comments

- **Concern ID** R1-m1
- **Severity** Minor
- **Axis** Clarity of terminology
- **Affected element** Definition of "one-shot learning"
- **Evidence pointer** Abstract text, location not provided
- **Issue** The term "one-shot learning" is used without definition, which may confuse readers unfamiliar with machine learning terminology.
- **Required correction** Provide a brief definition or context for one-shot learning in the introduction or abstract, such as "a machine learning paradigm where models are trained from very few examples per class."

- **Concern ID** R1-m2
- **Severity** Minor
- **Axis** Scope justification
- **Affected element** Method selection rationale
- **Evidence pointer** Abstract text, location not provided
- **Issue** The abstract lists six methods but does not explain why these were selected over other possible approaches, such as transfer learning or data augmentation.
- **Required correction** Add a sentence in the abstract or introduction justifying the method selection, for example, "These methods were chosen because they address different stages of the drug discovery pipeline and have shown recent progress in data-scarce settings."

- **Concern ID** R1-m3
- **Severity** Minor
- **Axis** Temporal scope
- **Affected element** Literature coverage window
- **Evidence pointer** Abstract text, location not provided
- **Issue** The abstract states "within the last five years" but does not specify the exact period, which could lead to ambiguity.
- **Required correction** Specify the exact years covered, for example, "from 2017 to 2022," to clarify the scope of the review.

## Risk / unsupported claims
- The claim that the reviewed methods "may be used to amplify the amount of available data" is plausible but unsupported by specific evidence in the abstract.
- The assertion that "recent works have successfully used these techniques" is unverifiable without references or case details.
- The statement that "it is possible to improve and kickstart research from scarce available data" is a general conclusion that lacks quantitative support.
- The relevance of the methods to "intrinsically disordered proteins" and "adverse effects" is mentioned but not elaborated, making the claim unassessable.